logo image
search icon
IPSC Characterization Kit Market

iPSC Characterization Kit Market Size, Share & Trends Analysis Report By Type (Alkaline Phosphatase Staining Assay, Pluripotency Markers (Protein), Pluripotency Markers (mRNA)), By Application, By Region, And By Segment Forecasts, 2024-2031

Report ID : 1418 | Published : 2024-02-22 | Pages: 185 | Format: PDF/EXCEL

The iPSC Characterization Kit Market Size is predicted to grow at an 15.54 % CAGR during the forecast period for 2024-2031.

Key Industry Insights & Findings from the Report:

  • The advent of the iPSC characterization kit market arose for technological innovation, regulatory support, and collaborative partnerships that propel stem cell research forward.
  • The increasing applications in research and therapy are expected to drive this market’s growth.
  • North America dominated the market and accounted for a global revenue share in 2023.
  • One of the significant concerns restraining industry growth is the high cost associated with stem cell therapy.

ipsc

A variety of delicate instruments are included in the iPSC characterization kit (induced pluripotent stem cell) for the phenotypic evaluation of the pluripotent state of human embryonic stem & induced pluripotent stem cells. Compared to embryonic stem cells (ESCs), induced pluripotent stem cells have several advantages, including avoiding the ethical concerns surrounding stem cells and offering the most significant degree of versatility for use in cell-based research. In recent years, these benefits have given induced pluripotent stem cells (iPSCs) a considerable boost, establishing a promising market for iPSC characterization kits. The strong pipeline for cell therapies derived from iPSCs and new iPSC applications is expected to accelerate market growth. Furthermore, the demand for iPSC characterization kits is expanding as a result of an increase in the prevalence of chronic diseases.

Additionally, induced pluripotent stem cells can be used to treat chronic diseases like diabetes, cancer, cancer, and heart disease, hence driving the iPSC characterization kit market. According to the Partnership to Fight Chronic Disorder (PFCD) survey, out of 133 million Americans, 45% of the population had at least one chronic disorder. In addition, it was calculated that chronic diseases account for 7 out of 10 deaths in the USA or roughly 1.7 million deaths, and that induced pluripotent stem cell therapy can prevent these deaths. Hence, the increased demand for induced pluripotent stem cell therapy is being driven by this surge in the prevalence of chronic disorders, which aids in the iPSC characterization kit market expansion.

Competitive Landscape

Some Major Key Players In The iPSC Characterization Kit Market:

  • Merck KGaA,
  • Takara Bio,
  • Thermo Fisher Scientific,
  • BD Biosciences,
  • Applied StemCell,
  • Amsbio,
  • Bio-Techne,
  • ALSTEM,
  • STEMCELL Technologies,
  • System Biosciences,
  • Applied Biological Materials,
  • Creative Bioarray,
  • Elixirgen Scientific
  • Miltenyi Biotec.

Market Segmentation:

The iPSC characterization kit market is segmented by type and application. Based on the type, the market is segmented into alkaline phosphatase staining assay, pluripotency markers (protein) and pluripotency markers (mRNA). Based on the application, the market is segmented into cancer research center, pathology laboratory, academic and research, contract research organizations and others.

Based On The Type, The Alkaline Phosphatase Staining Assay Category Is Accounted As A Major Contributor To The iPSC Characterization Kit Market.

The alkaline phosphatase staining assay category dominated the market in 2021. It is a stem cell imaging product used to stain pluripotent stem cells (PSCs) differentially. Over two hours, the dye diffuses out and acts as a cell-permeable fluorescent substrate for alkaline phosphatase (AP) that is non-toxic to cells. A high signal above the background enables the identification of pluripotent stem cells. Since it preserves stem cell viability, the alkaline phosphatase live stain is perfect for colony screening in the early stages of the reprogramming procedure. It can also be employed as a negative selection method to spot undifferentiated cells in advanced phases.

The Contract Research Organizations Category Witnessed Growth At A Rapid Rate.

The contract research organizations category dominated the market in 2021 due to the expanding emphasis on stem cell cytology and pathophysiology research and the expansion of public-private funding to assist the development and commercialization of stem cell products. A corporation that supports the pharmaceutical, biotechnology, and medical device sectors by contracting out research activities is known as a contract research organization (CRO). A CRO might offer commercialization, clinical trial management, pharmacovigilance, clinical development, outcomes research, and real-world evidence, among other services.

The North American iPSC Characterization Kit Market Holds A Signification Revenue Share.

The North American iPSC characterization kit market is expected to register the highest market share. Vital industry players are well represented in the area, and significant private and public financing for research institutes is a key factor in this situation. In addition, developing the iPSC characterization kit market is aided by a robust infrastructure for R&D and application scenarios, including tissue engineering and toxicity screening. It is projected that the region will maintain its dominance. In addition, Asia Pacific is projected to increase in the global iPSC characterization kit market. Induced pluripotent stem cell use is anticipated to be fueled by substantial market expansion in nations like Japan and China, as well as growing interest in regenerative medicine in the area, which will further fuel the growth of the iPSC characterization kit market. Although there isn't a clear legislative framework for the iPSC business, regional governments are making concerted attempts to change that. Those efforts are anticipated to support the development of the iPSC characterization kit market.

Recent Developments:

  • In August 2021, Fate Therapeutics officially declared that FT819 had been successful in treating its first patient in a clinical trial. FT819, which is a CAR-T cell treatment, was made utilizing iPSCs. 
  • In May 2022, Sernova and Evotec discussed a strategic treaty to develop an IPSC-based beta substitute therapy for type 1 and 2 diabetes.
  • In July 2021, SCM Lifescience Co. Ltd., a South Korea-based cell therapy developing firm, pronounced that it had in-license a diabetes drug from Allele Biotechnology and Pharmaceuticals, Inc., which is a pancreatic beta cell therapy extracted from IPSCs, and the deal has been signed at a valuation of US$ 0.75 million.

iPSC Characterization Kit Market Report Scope

Report Attribute

Specifications

Growth Rate CAGR

CAGR of 15.54 % from 2024 to 2031

Quantitative Units

Representation of revenue in US$ Million and CAGR from 2024 to 2031

Historic Year

2019 to 2023

Forecast Year

2024-2031

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

Type, Application

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia

Competitive Landscape

Merck KGaA, Takara Bio, Thermo Fisher Scientific, BD Biosciences, Applied StemCell, Amsbio, Bio-Techne, ALSTEM, STEMCELL Technologies, System Biosciences, Applied Biological Materials, Creative Bioarray, Elixirgen Scientific and Miltenyi Biotec.

Customization Scope

Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing And Available Payment Methods

Explore pricing alternatives that are customized to your particular study requirements.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global iPSC Characterization Kit Market Snapshot

Chapter 4. Global iPSC Characterization Kit Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: by Product Type Estimates & Trend Analysis

5.1. by Product Type & Market Share, 2019 & 2031

5.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Product Type:

5.2.1. Alkaline Phosphatase Staining Assay

5.2.2. Pluripotency Markers (Protein)

5.2.3. Pluripotency Markers (mRNA)

Chapter 6. Market Segmentation 2: by Application Estimates & Trend Analysis

6.1. by Application & Market Share, 2019 & 2031

6.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Application:

6.2.1. Cancer Research Center

6.2.2. Pathology Laboratory

6.2.3. Academic and Research

6.2.4. Contract Research Organizations

6.2.5. Others

Chapter 7. iPSC Characterization Kit Market Segmentation 3: Regional Estimates & Trend Analysis

7.1. North America

7.1.1. North America iPSC Characterization Kit Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2019-2031

7.1.2. North America iPSC Characterization Kit Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031

7.1.3. North America iPSC Characterization Kit Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031

7.2. Europe

7.2.1. Europe iPSC Characterization Kit Market revenue (US$ Million) by Product Type, 2019-2031

7.2.2. Europe iPSC Characterization Kit Market revenue (US$ Million) by Application, 2019-2031

7.2.3. Europe iPSC Characterization Kit Market revenue (US$ Million) by country, 2019-2031

7.3. Asia Pacific

7.3.1. Asia Pacific iPSC Characterization Kit Market revenue (US$ Million) by Product Type, 2019-2031

7.3.2. Asia Pacific iPSC Characterization Kit Market revenue (US$ Million) by Application, 2019-2031

7.3.3. Asia Pacific iPSC Characterization Kit Market revenue (US$ Million) by country, 2019-2031

7.4. Latin America

7.4.1. Latin America iPSC Characterization Kit Market revenue (US$ Million) by Product Type, 2019-2031

7.4.2. Latin America iPSC Characterization Kit Market revenue (US$ Million) by Application, 2019-2031

7.4.3. Latin America iPSC Characterization Kit Market revenue (US$ Million) by country, 2019-2031

7.5. Middle East & Africa

7.5.1. Middle East & Africa iPSC Characterization Kit Market revenue (US$ Million) by Product Type, 2019-2031

7.5.2. Middle East & Africa iPSC Characterization Kit Market revenue (US$ Million) by Application, 2019-2031

7.5.3. Middle East & Africa iPSC Characterization Kit Market revenue (US$ Million) by country, 2019-2031

Chapter 8. Competitive Landscape

8.1. Major Mergers and Acquisitions/Strategic Alliances

8.2. Company Profiles

8.2.1. Merck KGaA

8.2.2. Takara Bio

8.2.3. Thermo Fisher Scientific

8.2.4. BD Biosciences

8.2.5. Applied StemCell

8.2.6. Amsbio

8.2.7. Bio-Techne

8.2.8. ALSTEM

8.2.9. STEMCELL Technologies

8.2.10. System Biosciences

8.2.11. Applied Biological Materials

8.2.12. Creative Bioarray

8.2.13. Elixirgen Scientific

8.2.14. Miltenyi Biotech

8.2.15. Other Prominent Players

Segmentation of iPSC Characterization Kit Market-

By Type-

  • Alkaline Phosphatase Staining Assay
  • Pluripotency Markers (Protein)
  • Pluripotency Markers (mRNA)

ipsc

By Application-

  • Cancer Research Center
  • Pathology Laboratory
  • Academic and Research
  • Contract Research Organizations
  • Others

By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

 

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

What is the IPSC Characterization Kit Market Growth?

Merck KGaA, Takara Bio, Thermo Fisher Scientific, BD Biosciences, Applied StemCell, Amsbio, Bio-Techne, ALSTEM, STEMCELL Technologies, Others

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Pharmaceuticals

Select Licence Type
$4456
$7786
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach